| ²é¿´: 1163 | »Ø¸´: 10 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
[½»Á÷]
¡¾Ô´´¡¿¶Ô¿µÄùµÒ¸ñ´óѧÁ˽âµÄÅóÓÑ¿´¹ýÀ´£¨ÓÐ40½ð±Ò·îËÍ£©£¡£¡
|
|||
|
¸÷λ¶Ô¿µÄùµÒ¸ñ´óѧÁ˽âµÄ´óÏÀ£¬Çë°ïæ Õ⼸ÌìÀϰå´òËã°ïÎÒÍÆ¼öµ½¿µÄùµÒ¸ñ´óѧ×ö²©ºó µ«ÎÒ¶Ô¸ÃУÓÈÆäÊÇÄ¿±êµ¼Ê¦ÖªÖ®ÉõÉÙ£¬±Ï¾¹ÓÖÊÇÀϰå½éÉܵģ¬Èç¹ûóȻ´ðÓ¦Ï벻ȥ¾Í²»ºÃÁË£¬µ«Ò²²»ÄÜÍÏÌ«¾Ã£¬×ÜÒª¸øËû¸ö´ð¸´µÄ¡£ ÏȲ»Ëµ·Ï»°ÁË£¬°ÑÄ¿±êÀϰåÐÅÏ¢ÌùÉÏÀ´°É ´ó¼Ò°ïÎÒÄøöÖ÷Òâ Diane J. Burgess Ph.D. Board of Trustees Distinguished Professor Professor of Pharmaceutics University of Connecticut School of Pharmacy ËäÈ»¾Ý˵·¢¹ý100ƪÒÔÉÏÎÄÕ£¬µ«´ó¶àÔÚ3-5·ÖÖ®¼ä£¬×î¸ßµÄ6.5£¬Ò²Óкܶà2·ÖÒÔϵģ¬Í·ÏκÃÏñͦ¶à£¬ÊÇÊ²Ã´ÌØÆ¸½ÌÊÚʲôлáÖ÷ϯʲôҩµäίԱ»áÉúÎïÖÆÒ©ÆÀÉóר¼ÒµÈ£¬ÄùýÁ½´ÎУÓÅÐã½Ìʦ½±¡£ÎÒ×ܾõµÃËý²àÖØÓÚ½ÌѧºÍÐÐÕþ£¬Òª²»È»Ó¦¸ÃÓÐ10·ÖÒÔÉϵÄÎÄÕ³öÀ´µÄ¡£ ËýµÄ·½ÏòºÍÎҵĺÜÎǺϣ¬ÊÇ×ö¸ß·Ö×ÓÒ©ÎïÔØÌåµÄ£¬Ñо¿½çÃæ»¯Ñ§£¬Ò©Îï¿ØÊ͵ȣ¬Èç¹ûÈ¥ÁË£¬¾Í²»ÓÃΪ¹¤×÷ºÍ¸÷ÖÖÉêÇë·³ÐÄ£¬Ö»ÊÇÈ¥ÁËÈç¹ûûÓÐºÜºÃµÄÆ½Ì¨·¢µãÅ£µÄpaper£¬Ò²ÊDz»Ì«ÖµµÃµÄ¡£±¾ÈËÏÖÔÚÓÖÈýƪ3.0ÒÔÉÏÎÄÕ£¬journal of controlled release, nanotechnology, pharmaceutical research. ×ܾõµÃÎÒÔÚ¹úÄÚÒѾÓÐ5·ÖµÄÎÄÕÂÁË£¬ÔÙµ½¹úÍâÐÁÐÁ¿à¿à»¹ÊǺÜÄÑ·¢7·ÖÒÔÉϵÄÎÄÕ£¬×ܾõµÃÓе㲻ÇéÔ¸£¬µ«ÊÇÕâ±Ï¾¹ÊÇ»ú»á£¬ÏÖÔÚ³ö¹úÒ²ÊǺܷ³¶øÇÒÒ²²»ÈÝÒ×ÕÒµ½Ì«Å£µÄʵÑéÊÒ¡£ÎҺܳÇë´ó¼Ò°ïæ¡£ £¨ÒÔÏÂÊÇËýµÄÏêϸÇé¿ö£¬ÇëÈÈÐÄ´óÏÀÂÔ¿´£¬Ð»Ð»£¡£¡£© Diane J. Burgess Ph.D. Board of Trustees Distinguished Professor Professor of Pharmaceutics University of Connecticut School of Pharmacy, Room 432 69 North Eagleville Road, Unit 3092 Storrs, Connecticut 06269-3092 Phone: (860) 486-3760 Fax: (860) 486-2076 E-Mail: d.burgess@uconn.edu Educational Background ◊ Postdoctural Research, Universities of Amsterdam, Nottingham, and North Carolina ◊ Ph.D., University of London, United Kingdom ◊ B.Sc., University of Strathclyde, Glasgow, United Kingdom Professional Accomplishments Dr. Burgess was the recipient of the Outstanding Teacher of the Year Award (2005 and 1992). She was the 2002 President of the American Association of Pharmaceutical Scientists (AAPS) and is an AAPS fellow. She was recently elected Vice President of the Controlled Release Society and will be the 2009-2010 President. She is currently a member of the USP Biopharmaceuticals Expert committee and is a member of the USP Advisory Panel on Injectables. Dr. Burgess was an editor for AAPSharmsci (1999-2005) and is editor of the Journal of Drug Delivery Science and Technology (2003-present) and serves on the editorial boards of: the Journal of Pharmacy and pharmacology (1997-present); the Journal of Microencapsulationi (1997-present); Crital Reviewers in Therapeutic Drug Carrier Systems (2004-present); the International Journal of Pharmaceutics (2004-present); and the Journal of Diabetes Science and Technology (2006-present). In 2001 she underook a sabbatical leave at the Office of Testing and Research at CDER, FDA. She consults for pharmaceutical, food, cosmetic and other engineering industries on issues related to dispersed systems, in vitro release testing, IVIVC, interfacial chemistry and particle size analysis. Professional Interests Dr. Burgess runs a multidisciplinary laboratory. Research efforts focus on drug delivery systems, in particular, nonoparticles, microspheres, emulsions, liposomes, hydrogels, and novel coatings for implantable devises as well as interfacial chemistry. Research interests include small molecule drugs, proteins, peptides and DNA therapeutics. Together with faculty in Chemistry (Dr. Fotios Papadimitrakopoulos) and Electrical Engineering (Dr. Faquir Jain), Dr. Burgess is developing a miniaturized, implantable biosensor for metabalic monitoring. The team is developing an implantable coating to control tissue response to implantable devices. Drs. Burgess and Papidimitrakopoulos are using quantum dots to investigate intracellular traficking of DNA therapeutics and vectors. Dr. Burgess' group is developing in vitro performance tests for controlled release parenterals products and has collaborations with both the Food and Drug Association (FDA) and the United States Pharmacopeia (USP). This work includes evaluation of in vitro and in vivo correlation (IVIVC) of controlled release parenterals and development of appropriate in vitro release testing methods. Other important research areas are investigation of both nanoparticle and emulsion stability using a variety interfacial techniques and particle size analysis. Selected Recent Publications (out of over 100 publications) 1. B.S. Zolnik, and D.J. Burgess*. Evaluation of In vivo - In vitro Release of Dexamethasome from PLGA Microspheres. J. Controlled Release 2008 (127) 137-145. 2. U. Bhardwaj, R. Sura, F. Papadimitrakopoulos, and D.J. Burgess*. Controlling Acute Inflammation with fast-releasing dexamethasone PLGA microsphere/PVA hydrogel composites for implantable devices. Journal of Diabetes Science and Technology 2007, 1(1) 8-17. 3. S.D. Patil, F. Papidimitrakopoulos, and D.J. Burgess*. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J. Controlled Release 2007, 117(1) 68-79. 4. C. Srinivasan, J. Lee, F. Papadimitrakopoulos, L.K. Silbart, M.H. Zhao and D.J. Burgess*. Labeling and intracellular tracking of functionally active plasmid DNA with semiconductor quantum dots. Molecular Therapy 2006, 14(2) 192-201. 5. S.D. Patil, D.G. Rhodes, and D.J. Burgess*. Bio-physical characterization of a novel anionic liposomal delivery system. Biochimica et Biophysica Acta. 2005; 1711(1):1-11. Top ten most downloaded articles of 2005 in BBA. 6. S.D. Patil, D.G. Rhodes and D.J. Burgess*. DNA-based therapeutics and their delivery systems: A comprehensive review. The AAPS J. 2005;7(1):article 9. 2007 Outstanding Manuscript Award, The AAPS Journal 7. S.D. Patil, D.G. Rhodes and D.J. Burgess*. Anionic liposomal delivery system for DNA transfection. The AAPS J. 2004:6(4);article 29. 8. J. Jiao and D.J. Burgess*. Ostwald ripening of water-in-hydrocarbon emulsions. J. Coll. Interface Sci. 2003;264(2):506-516. |
» ²ÂÄãϲ»¶
°ßÂíÓã·õ»¯ÇóÖú
ÒѾÓÐ0È˻ظ´
Ͷ¸åElsevierµÄNeoplasiaÔÓÖ¾£¬µ½×îºóÑ¡publishing optionsÊ±Ò³Ãæ¿Õ°×£¬²»ÄÜÍê³ÉͶ¸å
ÒѾÓÐ23È˻ظ´
ÉúÎïÎïÀí¡¢ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ165È˻ظ´
ÉúÎïѧ-΢ÉúÎïѧ-²©Ê¿ÉêÇ룬ÓзÖ×ÓÉúÎïѧ¡¢·¢½Í¹¤³Ì¡¢ÉúÎïÐÅϢѧµÈ»ù´¡
ÒѾÓÐ1È˻ظ´
ϤÄá´óѧ AMME »úе¹¤³Ì Ë«ARC Future FellowsÍŶÓÕÐÊÕCSC²©Ê¿Éú
ÒѾÓÐ30È˻ظ´
2026 ·¨¹úcsc ¸öÈËÇþµÀÕÐÆ¸¡£¼ÆËã»ú/ÉúÎïÐÅÏ¢/evolution/networkÓÅÏÈ
ÒѾÓÐ0È˻ظ´
µ°°×Ìõ´øÍá
ÒѾÓÐ1È˻ظ´
½ðÊôÀë×ÓÓ뻯ºÏÎï·Ö×Ó¶Ô½Ó
ÒѾÓÐ1È˻ظ´
ÇóÖú²ÎÜß°×Êõ¿Ú·þÒº¡¢·Ê¶ù¿Ú·þÒº£¬¶ù¿µÄþÌǽ¬µÄÖÊÁ¿±ê×¼£¡
ÒѾÓÐ2È˻ظ´
Ïã¸ÛÖÐÎÄ´óѧҽѧԺ ³ÏƸ Ñо¿ÖúÀí½ÌÊÚ (Ò½¹¤½áºÏ/ÉúÎïÐÅϢѧ·½Ïò)
ÒѾÓÐ21È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
travelerchem
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 18747
- ºì»¨: 3
- Ìû×Ó: 5156
- ÔÚÏß: 286.3Сʱ
- ³æºÅ: 295226
- ×¢²á: 2006-11-11
- ÐÔ±ð: GG
- רҵ: Óлú·Ö×Ó¹¦ÄܲÄÁÏ»¯Ñ§
¡ï ¡ï
cpucqzj(½ð±Ò+2,VIP+0): 10-27 08:21
Þ¹Ò²ݶù(½ð±Ò+0,VIP+0):»¶ÓÌÖÂÛ~ 10-27 10:51
cpucqzj(½ð±Ò+2,VIP+0): 10-27 08:21
Þ¹Ò²ݶù(½ð±Ò+0,VIP+0):»¶ÓÌÖÂÛ~ 10-27 10:51
| Èç¹û×Ô¼ºÁªÏµ²»µ½¸üºÃµÄµ¼Ê¦»òÊÇʵÑéÊÒ£¬»¹ÊÇ¿ÉÒÔ¿¼ÂÇÈ¥ÄDZß×öµÄ¡£ |
2Â¥2009-10-26 23:41:39
hxp207
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 120 (¸ßÖÐÉú)
- ¹ó±ö: 0.03
- ½ð±Ò: 9574.4
- É¢½ð: 50
- ºì»¨: 4
- Ìû×Ó: 1054
- ÔÚÏß: 247.6Сʱ
- ³æºÅ: 297989
- ×¢²á: 2006-11-18
- רҵ: ´ß»¯»¯Ñ§
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
cpucqzj(½ð±Ò+5,VIP+0): 10-27 08:20
cpucqzj(½ð±Ò+5,VIP+0):ÇëÎÊÄãÏÖÔÚ»¹ºÍÄãͬѧÁªÏµÂð Äܲ»ÄÜÌṩËûµÄÁªÏµ·½Ê½ ÎÒ¼±ÓÃµÄ Ð»Ð»°¡ 10-27 08:21
Þ¹Ò²ݶù(½ð±Ò+1,VIP+0):»¶ÓÌÖÂÛ~ 10-27 10:50
cpucqzj(½ð±Ò+5,VIP+0): 10-27 08:20
cpucqzj(½ð±Ò+5,VIP+0):ÇëÎÊÄãÏÖÔÚ»¹ºÍÄãͬѧÁªÏµÂð Äܲ»ÄÜÌṩËûµÄÁªÏµ·½Ê½ ÎÒ¼±ÓÃµÄ Ð»Ð»°¡ 10-27 08:21
Þ¹Ò²ݶù(½ð±Ò+1,VIP+0):»¶ÓÌÖÂÛ~ 10-27 10:50
| Ò»¸öͬѧÔÚÄÇÀÔÚÃÀ¹ú¶«²¿£¬×ÔÈ»»·¾³ºÜ²»´í£¬Ñ§Ð£¼¸ºõ¾ÍÔÚÉÁÖÀï¡£ÆøºòËļ¾·ÖÃ÷£¬Îï¼Û£¬Ïû·ÑÒª¸ßһЩ¡£ |
3Â¥2009-10-27 07:50:56
mryingzi
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 30.7
- É¢½ð: 25
- ºì»¨: 1
- Ìû×Ó: 86
- ÔÚÏß: 86.8Сʱ
- ³æºÅ: 847895
- ×¢²á: 2009-09-14
- רҵ: ÉúÎïÒ½Óø߷Ö×Ó²ÄÁÏ
¡ï ¡ï ¡ï
cpucqzj(½ð±Ò+3,VIP+0):лл£¡£¡ 10-28 08:11
cpucqzj(½ð±Ò+3,VIP+0):лл£¡£¡ 10-28 08:11
|
²»´íµÄѧУ ÆäʵÈç¹ûÊÇÍÆ¼öµÄ»° ¿ÉÒÔÏÈÈ¥ È»ºóÔÚÕÒ»ú»áÌøµ½¸üºÃµÄѧУÁË ¹Ø¼üÊÇÏÈÈ¥ÄÇÀï ²ÅÓбȽϴóµÄ»ú»áÌø ÈÏʶһ¸öÈËÈ¥ÁË100ÒÔÍâµÄÒ»¸öÀÃУ×ö²©ºó×öÁË1Äê²»µ½£¬Ìøµ½ÁËTOp10µÄѧУ Â¥Ö÷»¹ÊÇҪץס»ú»áÁË£¬ÏÖÔÚÕÒ²©ºóְλ»¹ÊÇͦÄÑÕҵģ¬Óлú»á¿ÉÒÔÏÈÕ¼¸ö¿ÓÁË |
4Â¥2009-10-27 19:09:10
mryingzi
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 30.7
- É¢½ð: 25
- ºì»¨: 1
- Ìû×Ó: 86
- ÔÚÏß: 86.8Сʱ
- ³æºÅ: 847895
- ×¢²á: 2009-09-14
- רҵ: ÉúÎïÒ½Óø߷Ö×Ó²ÄÁÏ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
cpucqzj(½ð±Ò+10,VIP+0):ÊÇÂð£¿ÔÚIJPµÄ¹Ù·½ÍøÒ³ÄÜ¿´µ½Âð£¿ÇëÎÊÄ㻹ÓÐʲôºÃµÄÐÅÏ¢Â𣿠11-1 18:17
cpucqzj(½ð±Ò+10,VIP+0):ÊÇÂð£¿ÔÚIJPµÄ¹Ù·½ÍøÒ³ÄÜ¿´µ½Âð£¿ÇëÎÊÄ㻹ÓÐʲôºÃµÄÐÅÏ¢Â𣿠11-1 18:17
| ×î½ü·¢ÏÖÕâ¸öÈËÊÇIJPµÄ¸±Ö÷±à Ó¦¸ÃҲСÓÐÃûÆø°É |
5Â¥2009-11-01 15:52:16
mryingzi
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 30.7
- É¢½ð: 25
- ºì»¨: 1
- Ìû×Ó: 86
- ÔÚÏß: 86.8Сʱ
- ³æºÅ: 847895
- ×¢²á: 2009-09-14
- רҵ: ÉúÎïÒ½Óø߷Ö×Ó²ÄÁÏ
¡ï ¡ï
cpucqzj(½ð±Ò+2,VIP+0):ллÄãÌṩµÄ±¦¹óÐÅÏ¢ 11-2 08:17
cpucqzj(½ð±Ò+2,VIP+0):ллÄãÌṩµÄ±¦¹óÐÅÏ¢ 11-2 08:17
|
ÔÚIJPµÄeditor board ÄÇÀï¿ÉÒÔ¿´µ½ ËûÊǸºÔðÃÀ¹ú¡¢°Ä´óÀûÑǺÍÐÂÎ÷À¼¸å¼þµÄ Õâ¸öÈËÓ¦¸Ã²»´í£¬ÄÜ×öµ½IJPµÄ¸±Ö÷±àÓ¦¸ÃºÜºÃÁË |
6Â¥2009-11-01 19:10:07
aegeansyang
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 12 (СѧÉú)
- ½ð±Ò: 5517.1
- É¢½ð: 1825
- ºì»¨: 5
- Ìû×Ó: 856
- ÔÚÏß: 724.4Сʱ
- ³æºÅ: 243919
- ×¢²á: 2006-04-16
- ÐÔ±ð: GG
- רҵ: ×éÖ¯¹¤³Ìѧ
¡ï ¡ï ¡ï ¡ï
cpucqzj(½ð±Ò+4,VIP+0):ллÆÀ¼Û£¬ÎÒµÄÐÅÐÄÒ²ÊÇÔ½À´Ô½´óÁË 11-3 23:53
cpucqzj(½ð±Ò+4,VIP+0):ллÆÀ¼Û£¬ÎÒµÄÐÅÐÄÒ²ÊÇÔ½À´Ô½´óÁË 11-3 23:53
| ¶øÇÒÔøÊÇAAPSµÄÖ÷ϯ. Õâ¸öÒѾËãÂùÅ£µÄÁË. ÖÆÒ©µÄÒ²¾ÍÊÇÕâЩÔÓÖ¾°¡...¶¼ÔÚ3-5·Ö×óÓÒ. JCR, PHARM RES, MOLECULAR PHARMACEUTICS, JPET, GENE THERAPY, MOLECULAR THERAPY, BIOMATERIALS....µ«¶¼ÊÇÖ÷Á÷ÔÓÖ¾°¡, ÄãÅ£Ò²¿ÉÒÔ·¢PNASÖ®Àà µÄ. |
7Â¥2009-11-03 19:08:13
zoujie
Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 45 (СѧÉú)
- ½ð±Ò: 5664.1
- É¢½ð: 350
- ºì»¨: 7
- Ìû×Ó: 3257
- ÔÚÏß: 772.1Сʱ
- ³æºÅ: 446890
- ×¢²á: 2007-10-30
- ÐÔ±ð: GG
- רҵ: Ò½ÓÃÉúÎï²ÄÁÏÓëÖ²Èë¿ÆÑ§
8Â¥2009-11-11 17:04:27
xhyu2936
½ð³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 694.7
- Ìû×Ó: 20
- ÔÚÏß: 10.3Сʱ
- ³æºÅ: 262245
- ×¢²á: 2006-06-25
- רҵ: biomaterial
¡ï
Þ¹Ò²ݶù(½ð±Ò+1,VIP+0):»¶ÓÌÖÂÛ~ 11-13 09:30
Þ¹Ò²ݶù(½ð±Ò+1,VIP+0):»¶ÓÌÖÂÛ~ 11-13 09:30
|
Fotios Papadimi, ¹À¼ÆËûµÄpublication ±È½Ï¶ÔÄãµÄθ¿Ú¡£ ²»¹ý»°Ëµ»ØÀ´£¬½ð×Óµ½ÄÇÀï¶¼ÄÜ·¢¹â¡£ÄãÌôÀϰåÕâôpicky, ²»ÖªµÀ£¡ |
9Â¥2009-11-12 08:07:29
stent
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 1787
- É¢½ð: 1
- ºì»¨: 2
- Ìû×Ó: 1094
- ÔÚÏß: 81Сʱ
- ³æºÅ: 545958
- ×¢²á: 2008-04-15
- ÐÔ±ð: GG
- רҵ: ½ðÊô¹¦ÄܲÄÁÏ
¡ï ¡ï ¡ï ¡ï ¡ï
Þ¹Ò²ݶù(½ð±Ò+2,VIP+0):»¶ÓÌÖÂÛ~ 11-13 09:30
cpucqzj(½ð±Ò+3,VIP+0): 11-14 01:04
Þ¹Ò²ݶù(½ð±Ò+2,VIP+0):»¶ÓÌÖÂÛ~ 11-13 09:30
cpucqzj(½ð±Ò+3,VIP+0): 11-14 01:04
| ²»Äܹ⿴ӰÏìÒò×ӵ쬻¹Òª¿´ËýµÄÎÄÕÂÔÚÕâ¸öÁìÓòµÄÓ°ÏìÁ¦£¬±ÈÈç±»ÒýÓõĴÎÊý¡¢Ìá³öµÄÀíÂÛ¶Ô±ðÈ˵ÄÓ°Ïì¡¢Éè¼ÆµÄÊÔÑé·½·¨¶Ô±ðÈ˵ÄÓ°ÏìʲôµÄ¡£ÀýÈçijÈ˹àË®ÁËһƪnature£¬µ«ºóÀ´»ù±¾Ã»ÈË×¢Òâ¹ýÕâÆªÎÄÕ£¬ÕâÓÖÓÐʲôÒâË¼ÄØ£¿ÓÐЩÁìÓòµÄÆÚ¿¯Ó°ÏìÒò×ÓÕûÌ岻̫¸ß£¬lzÒª´Ó³¤Ô¶¿¼ÂÇ£¬²»Äܶ¢×ÅIF²»·Å£¬»¹ÐèÒª×ۺϿ¼ÂÇ¡£ÆäʵÎÒ¾õµÃËäÈ»¶ÔÀÏʦ²»Á˽⣬µ«Ñ§Ð£»¹²»´í£¬ÖÜΧµÄ¿ÆÑзÕΧҲÐí»áºÜºÃ£¬Õâ¾ÍÓкܴóµÄ»ú»á½Ó´¥µ½Å£¡£ |
10Â¥2009-11-12 20:34:48













»Ø¸´´ËÂ¥